Fineotex Chemical Ltd
Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries[1]
- Market Cap ₹ 3,871 Cr.
- Current Price ₹ 33.2
- High / Low ₹ 35.8 / 19.0
- Stock P/E 35.6
- Book Value ₹ 7.58
- Dividend Yield 0.24 %
- ROCE 18.3 %
- ROE 13.5 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Debtor days have increased from 102 to 137 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Commodities BSE 1000
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102 | 110 | 127 | 141 | 182 | 196 | 219 | 368 | 517 | 569 | 533 | 772 | |
| 85 | 82 | 98 | 111 | 148 | 162 | 178 | 297 | 404 | 421 | 406 | 637 | |
| Operating Profit | 16 | 28 | 29 | 30 | 34 | 35 | 41 | 71 | 113 | 148 | 127 | 135 |
| OPM % | 16% | 26% | 23% | 21% | 19% | 18% | 19% | 19% | 22% | 26% | 24% | 17% |
| 5 | 2 | 10 | 5 | 1 | -11 | 17 | 6 | 7 | 17 | 24 | 33 | |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 13 |
| Profit before tax | 20 | 29 | 38 | 34 | 34 | 22 | 56 | 73 | 115 | 158 | 141 | 153 |
| Tax % | 28% | 31% | 24% | 29% | 28% | 35% | 20% | 22% | 22% | 23% | 23% | 18% |
| 15 | 20 | 29 | 24 | 24 | 14 | 45 | 57 | 90 | 121 | 109 | 125 | |
| EPS in Rs | 0.11 | 0.16 | 0.23 | 0.20 | 0.20 | 0.12 | 0.38 | 0.50 | 0.80 | 1.08 | 0.94 | 0.93 |
| Dividend Payout % | 9% | 13% | 4% | 10% | 5% | 4% | 8% | 8% | 10% | 15% | 8% | 3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 29% |
| 3 Years: | 14% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 21% |
| 3 Years: | 7% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 32% |
| 3 Years: | 4% |
| 1 Year: | 41% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 21% |
| 3 Years: | 19% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 23 | 116 |
| Reserves | 54 | 69 | 90 | 113 | 137 | 147 | 187 | 240 | 327 | 425 | 708 | 766 |
| 2 | 3 | 1 | 5 | 2 | 3 | 3 | 2 | 7 | 5 | 0 | 8 | |
| 23 | 20 | 26 | 21 | 34 | 35 | 54 | 75 | 67 | 96 | 83 | 269 | |
| Total Liabilities | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 815 | 1,159 |
| 18 | 19 | 27 | 29 | 36 | 41 | 59 | 84 | 99 | 141 | 179 | 278 | |
| CWIP | 0 | -0 | -0 | 0 | 0 | 1 | 5 | -0 | 0 | -0 | 21 | 2 |
| Investments | 29 | 39 | 47 | 55 | 48 | 52 | 32 | 17 | 89 | 147 | 330 | 317 |
| 54 | 56 | 66 | 77 | 110 | 114 | 171 | 238 | 234 | 260 | 284 | 562 | |
| Total Assets | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 815 | 1,159 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 | 14 | 19 | 6 | 12 | 28 | 9 | 13 | 107 | 97 | 69 | -24 | |
| -14 | -13 | -14 | -6 | 5 | -19 | -7 | 1 | -99 | -47 | -273 | 105 | |
| -3 | -1 | -6 | -4 | -3 | -4 | -4 | -6 | -6 | -24 | 176 | -63 | |
| Net Cash Flow | -3 | -1 | -1 | -3 | 14 | 6 | -2 | 8 | 1 | 26 | -27 | 19 |
| Free Cash Flow | 8 | 12 | 14 | 4 | 4 | 22 | -15 | -9 | 88 | 49 | 1 | -49 |
| CFO/OP | 109% | 84% | 104% | 52% | 63% | 104% | 46% | 43% | 119% | 92% | 77% | -0% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 84 | 84 | 72 | 98 | 100 | 138 | 110 | 72 | 89 | 79 | 137 |
| Inventory Days | 56 | 66 | 70 | 97 | 84 | 66 | 79 | 98 | 53 | 55 | 75 | 109 |
| Days Payable | 75 | 75 | 82 | 50 | 70 | 73 | 101 | 96 | 53 | 79 | 66 | 114 |
| Cash Conversion Cycle | 60 | 75 | 72 | 119 | 112 | 93 | 116 | 111 | 72 | 64 | 88 | 133 |
| Working Capital Days | 58 | 73 | 73 | 114 | 118 | 107 | 136 | 125 | 71 | 76 | 104 | 153 |
| ROCE % | 21% | 31% | 35% | 26% | 22% | 20% | 28% | 30% | 36% | 39% | 24% | 18% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Count Count |
|
|||||||||||
| Market Reach (Countries) Count |
||||||||||||
| Sales Volume MT |
||||||||||||
| Installed Production Capacity MTPA |
||||||||||||
| Total SKUs Count |
||||||||||||
| Number of Dealers/Distributors Count |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
2d - Fineotex released Q4 FY26 earnings call transcript; revenue rose 162% to ₹314 crore, PAT up 118% to ₹44 crore.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18 May - Audio recording of Q4 FY2025-26 investor and analyst concall made available on website.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
16 May - Investor Presentation for the financial result of the company for the quarter and year ended March 31, 2026
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16 May - Q4 FY26 revenue ₹313.73 crore, PAT ₹43.79 crore; new Midland facility doubles CrudeChem capacity.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 May - Newspaper Publicatio of Annual Audited Financial Statement for the quarter and year ended March 31, 2026
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT
-
Dec 2025TranscriptPPT
-
Dec 2025TranscriptPPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024Transcript PPT REC
-
Aug 2024TranscriptAI SummaryPPT
-
Jun 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Mar 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Nov 2023TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
Jun 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
Apr 2022TranscriptAI SummaryPPT
-
Jan 2022Transcript PPT
-
Jan 2022TranscriptAI SummaryPPT
-
Nov 2021Transcript PPT
-
Nov 2021TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021Transcript PPT
-
Jul 2021TranscriptAI SummaryPPT
-
May 2021Transcript PPT
-
Apr 2021TranscriptAI SummaryPPT
-
Feb 2021Transcript PPT
-
Jan 2021TranscriptAI SummaryPPT
-
Jan 2021TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Sep 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptAI SummaryPPT
-
Jun 2018Transcript PPT
-
Jun 2018TranscriptAI SummaryPPT
-
Jun 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Dec 2017TranscriptAI SummaryPPT
-
Dec 2017TranscriptAI SummaryPPT
-
Sep 2017TranscriptAI SummaryPPT
-
Sep 2017TranscriptAI SummaryPPT
-
May 2017TranscriptAI SummaryPPT
-
Mar 2017Transcript PPT
-
Feb 2017TranscriptAI SummaryPPT
-
Nov 2016Transcript PPT
-
Nov 2016TranscriptAI SummaryPPT
-
Aug 2016Transcript PPT
-
Aug 2016TranscriptAI SummaryPPT
-
May 2016Transcript PPT
-
Mar 2016TranscriptAI SummaryPPT
-
Mar 2016TranscriptAI SummaryPPT
-
Feb 2016TranscriptAI SummaryPPT
-
Nov 2015TranscriptAI SummaryPPT
-
Aug 2015TranscriptAI SummaryPPT
Product Offerings[1]
The company manufactures over 470 specialty chemicals and enzymes catering to textiles, garments, construction, leather, water treatment, agrochemicals, adhesives and other industries across ~70 countries. The Company is a leading manufacturer of textile specialty and performance chemicals, offering products across the pre-treatment, dyeing, printing and finishing value chain. It has also expanded into the health and hygiene segment, including detergent and handwash products.